For those with major depression, there is a new treatment option - one that offers hope when patients are not responding to ...

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression ...

The synergistic relationship between psychiatric medications and psychotherapy is often overlooked. By managing discreet ...

Spravato, a newly FDA-approved nasal spray, offers hope for individuals with treatment-resistant depression, a condition ...

While antipsychotics can be effective for some patients, they come with well-known side effects, including an increased risk ...

Studies show that antidepressants don’t always work. One psychologist explains how to take control of negative thoughts ...